Systemic inflammation plays a major role in CAD etiopathogenesis [17] and routine inflammatory biomarkers (complete blood count, C-reactive protein) have proven their role for both acute and long-term cardiovascular risk assessment [18,19,20]. Here, CRP is linked to coronary artery disorder.